Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
personalized-treatment
Press Release
Dec 5, 2019
ARTIDIS Gains Strong Momentum in 2019, Raising CHF 8.8 Million in Seed Financing
ARTIDIS AG ("ARTIDIS"), a privately held healthtech company, announced today the successful closure of a CHF 8.8 million seed financing in two rounds, securing early clinical validation and the next development phase towards market entry in 2021.
Read More
Press Release
Nov 18, 2019
ARTIDIS Joins the TMC Accelerator Device Cohort to Ensure That Its Cancer Diagnostic and Therapeutic Optimization Innovation Gains Early Access to the US Market
ARTIDIS announces its successful integration in the highly competitive international Medical Device Cohort 2019 of the Texas Medical Center's (TMC) Innovation Institute.
Read More
First
Prev
1
Next
Last